News

Public · Published

Syngene International Q2 Results: Net profit tanks 52% on lower Zoetis revenue, forex hedge losses

Syngene International reported a 52% year-on-year fall in net profit to ₹32 crore for the second quarter of financial year 2026-27, down from ₹67 crore. Revenue fell 8.6% to ₹833 crore, and EBITDA declined 26% to ₹147.4 crore.

Published:

Updated:

What happened

Syngene International reported a 52% year-on-year fall in net profit to ₹32 crore for the second quarter of financial year 2026-27, down from ₹67 crore. Revenue fell 8.6% to ₹833 crore, and EBITDA declined 26% to ₹147.4 crore.

Confirmed

Global impact / market context

Lower Zoetis revenue and forex hedge losses, which are losses on contracts meant to offset currency swings, cut profit sharply. A narrower EBITDA margin, meaning less profit per sale after running costs, signals weaker operating efficiency and could pressure investor confidence.

Analyst inference

The results point to softer demand from a key client and currency-related costs hurting earnings. With profit down by half, investors may question near-term earnings stability, even as management points to early progress in its CDMO business, which is contract drug development and manufacturing.

Analyst inference

What to watch

  1. Watch whether Zoetis-related revenue recovers in coming quarters, since lower Zoetis revenue was cited as a reason for the profit decline. Confirmed
  2. Management plans to emphasize differentiated, high-value services and CDMO capabilities, so watch whether these efforts translate into revenue growth. Proposed
  3. Track forex hedge losses and EBITDA margin trends, because currency contracts and weaker profit per sale could keep weighing on earnings. Analyst inference

Evidence

  • Original source link unavailable